Credits: Canva
As per the latest data released by Transforming Access to Student Outcomes in Higher Education (TASO) and the Policy Institute at King's College London, the number of UK students reporting mental health difficulties tripled. The estimate reveals that around 300,000 students could now be experiencing mental health struggles. Of the total, 18% of students reported some kind of mental health issue in 2024.
As per the reports, this estimate is triple what was reported in 2017, where it was at 6%. Experts also say that Covid-19 pandemic is "often considered to have contributed to this, it does not explain the ongoing rise in mental health difficulties." Another reason could also be the "changing definition and increasing openness about mental health" which has led to a rise in numbers. The report notes, "This trend pre-dates the Covid-19 pandemic and the cost-of-living crisis. Although these factors play a part in students' deteriorating mental health, they cannot therefore be the only explanation."
The report drew data collected over the latest Student Academic Experience Survey of 93,212 students. From the survey, it was found that there exist significant disparities between demographic groups, with women being twice as likely to report mental health difficulties, about 22% as compared to men, at 11%.
The results revealed that students who identified as LGBTQ experienced the highest rates of mental health challenges. This has actually lessened the hope that conditions for LGBTQ students are improving, which may not have been a positive case.
Of them, 42% are bisexual and lesbian students, whereas last year it was 35% and 32% respectively. The report also noted that mental health difficulties among lesbian women and gay men rose three times the rate of straight people, and among bisexual and asexual people, it was twice as high. For trans students, the number jumped from 25% in 2023 to 40% in 2024.
As per the Child Mind Institute, being LGBTQ+ does not cause mental health problems, but because these kids often face factors like rejection, discrimination and violence, they are at a higher risk of challenges including depression, anxiety, and even attempting suicide.
A UTAH Health study quotes Anna Docherty, PhD, LP, assistant professor of psychiatry at Huntsman Mental Health Institute that, "likely with any identity, feeling different - or worse, unaccepted as you are is a significant risk factor of mental health struggle." The data reveals that LGBTQ+ teens are six times more likely to experience symptoms of depression than non-LGBTQ+ identifying teens. They are also more than twice as likely to feel suicidal and more than four times as likely to attempt suicide. In the US alone, 48% of transgender adults report that they have considered suicide in the last year, compared to 4% of the overall population.
TASO's academic lead and professor of public policy at King's College London, Michael Sanders said, "LGBTQ students and women bear the brunt of the rise in declining mental health and urgent action is needed to understand and address these trends."
Credit: Canva
Schizophrenia (SCZ), bipolar disorder (BD) and major depressive disorder may share the same genetic roots, a Nature study shows.
While experts have long classified each of these mental disorders as individual illnesses with their own causes, researchers from across China have discovered that these three diseases share about 70 percent common genetic and environmental risk factors.
Schizophrenia is a severe, chronic brain disorder that can lead psychosis, hallucinations, delusions, disorganized thinking and reduced emotional expression. It can affect how a person's thinks, feels and behaves, making it hard to distinguish reality.
While bipolar disorder is a chronic mental illness which causes extreme mood swings, from emotional highs (mania/hypomania) to lows (depression), affecting the brain's energy, activity and focus levels.
On the other hand, major depressive disorder or clinical depression, is a serious mood disorder that causes persistent sadness and loss of interest in a person. It can affect feelings, thoughts and daily activities and can be identified by symptoms such as low energy, sleep/appetite changes, guilt, concentration issues and thoughts of death.
Using advanced techniques, they identified 238 genetic variants that raise risk across multiple disorders and showed that five major genetic patterns explain most of the differences between people with and without mental illness.
Read More: Study Shows Depression Can Accelerate The Onset Of Chronic Illnesses
Based on these genetic patterns, the disorders clustered into five broad groups: internalizing conditions such as depression, anxiety and post-traumatic stress disorder; neurodevelopmental conditions including autism and attention-deficit hyperactivity disorder; substance use disorders; compulsive conditions such as obsessive-compulsive disorder and anorexia and lastly, a fifth group that included bipolar disorder and schizophrenia.
The findings explain why many individuals are diagnosed with more than one mental health condition as many genes affect multiple brain pathways. This indicates that the same genetic changes can lead to different disorders depending on other biological and environmental factors.
Even though medications such as antidepressants are useful in treating multiple mental illnesses including depression, anxiety and PTSD, the researchers concluded that more research is needed to understand the biology behind the genetic factors to understand the links between the disease.
One of the study’s authors compared the current system to diagnosing a patient with separate illnesses for a cough, sore throat and runny nose instead of recognizing a single underlying infection.
Nearly one in eight people globally, around 970 million individuals, were living with a mental disorder in 2021, with anxiety and depression being the most common globally.
Credit: Canva
Amazon has confirmed that 10 employees at its Coventry, UK warehouse have tested positive for tuberculosis (TB) as calls for site shutdown continue to grow.
Cases emerged at the hub, which has about 3,000 employees, in September 2025 and were found to be non-contagious. However, the retail giant acknowledged the breakout on January 16.
Officials from Amazon noted: "In line with best practice safety procedures, we immediately followed guidance from the NHS and UK Health Security Agency (UKHSA) and made all potentially affected employees aware of the situation. Out of an abundance of caution, we are currently running an expanded screening program with the NHS.
"We will continue to follow guidance from the experts in the NHS, and would respectfully remind public organizations of the need for responsible communications where matters of public wellbeing are concerned."
A spokesperson also assured that no new cases have been recorded in the area and a "screening program" being carried out amid "an abundance of caution" in collaboration with NHS and the UK Health Security Agency (UKHSA).
Since being diagnosed with TB, the unidentified patients have been receiving treatment from the UKHSA in West Midlands. Dr Roger Gajraj, consultant in health protection with UKHSA West Midlands also revealed that tests are being offered to those who may have had close contact with the patients and assured the overall risk remains low.
He told the BBC: "The small number of individuals affected by tuberculosis (TB) are responding well to treatment and are no longer infectious, so pose no onward risk.
"As a precaution, and in line with national guidance, we are offering testing to those who may have had closer contact with the affected individuals. The overall risk remains low. TB is fully treatable with antibiotics. We continue to work closely with Amazon to monitor the situation."
Read More: WHO’s Latest TB Guidelines Highlight Nutrition as Key to Treatment
Common signs and symptoms of TB include unexplained weight loss, loss of appetite, chills and fever, fatigue, getting night sweats, weakness or fatigue. Symptoms of TB disease in the lungs may include coughing up blood or sputum, a cough lasting for more than 3 weeks and chest pain.
TB is typically diagnosed through the Mantoux Tuberculin Skin Test(TST). Here, a small amount of tuberculin is injected into the skin of the forearm and is monitored for a reaction 48 to 72 hours after the injection. A positive skin test result indicates the presence of TB and there is a need for additional tests to determine to determine if it is active or latent.
If positive, blood tests are done to determine or rule out if the patient has active or latent TB. There are two blood tests approved by the Food and Drug Administration for TB- T-SPOT TB test(T-spot) and the QuantiFERON-TB Gold-In-Tube test(QFT-GIT). Doctors may also prescribe a chest X-ray or CT scan after a positive skin test.
Despite being preventable through vaccine and and curable through antibiotics, TB remains a leading infectious killer and causes over a million deaths annually worldwide, with millions falling ill each year.
In 2024, about 10.7 million people were diagnosed with TB out of which 1.23 million died from the disease.
Credits: Canva
The Tamil Nadu government has prohibited the manufacture, sale, distribution, and use of the cough syrup Almond Kit after laboratory testing confirmed it contained the highly toxic chemical ethylene glycol, according to a press release issued by the state’s drug control authority. Officials said the syrup, which is produced in Bihar, was found to be contaminated with ethylene glycol, a substance known to trigger serious and, in some cases, fatal health problems. But what exactly is ethylene glycol poisoning, and what health conditions can it cause?
The Tamil Nadu government has imposed a complete ban on the manufacture, sale, distribution, and consumption of the cough syrup Almond Kit after laboratory tests detected the presence of ethylene glycol, a highly dangerous chemical, the state drug control department said in a press statement. Citing news agency IANS, officials confirmed that the syrup is manufactured in Bihar and was found to be contaminated with ethylene glycol, a compound associated with severe and sometimes life-threatening health complications.
Ethylene glycol is a colourless, odourless liquid with a sweet taste, most commonly used in antifreeze. It may be consumed accidentally or intentionally, including in cases of self-harm. Once inside the body, ethylene glycol breaks down into glycolic acid and oxalic acid, which are responsible for most of its toxic effects.
According to Medline Plus, early symptoms of ethylene glycol poisoning include a feeling of intoxication, nausea, vomiting, and abdominal pain. As the poisoning progresses, symptoms can worsen and may include reduced consciousness, headaches, and seizures.
As per the US Centers for Disease Control and Prevention (CDC), exposure to ethylene glycol can result in severe and potentially fatal health conditions, particularly when ingested through contaminated medicines.
One of the most serious effects is acute kidney failure, which can develop rapidly and may cause the kidneys to shut down within a few days if treatment is delayed. Ethylene glycol can also harm the brain and nervous system, leading to confusion, poor coordination, seizures, and even coma.
The toxin can cause severe metabolic acidosis, a condition in which the blood becomes dangerously acidic, interfering with normal heart function and breathing.
In certain cases, ethylene glycol exposure can also lead to lung-related complications, including fluid accumulation in the lungs that makes breathing difficult.
Without prompt medical intervention, ethylene glycol poisoning can be fatal, especially in children and individuals with existing kidney or liver disease. This is why its detection in any oral medication is treated as a serious public health concern.
According to IANS, consumers have been advised to check for batch number AL24002 and strictly avoid using the syrup. People who already have the product have been asked to contact authorities for instructions on safe disposal. The Directorate has also stepped up inspections and monitoring across pharmacies and hospitals in Tamil Nadu to ensure the contaminated cough syrup is fully removed from circulation.
© 2024 Bennett, Coleman & Company Limited